Breast CT Clinical Data
Breast CT Technology Publication Synopsis
Dedicated Breast CT, Journal of Breast Imaging
Impact of Cone-Beam CT Noise Correlation on Self Supervised Denoising, Medical Imaging
Computer Aided Diagnosis of Masses in Breast CT, Journal of Medical Imaging
Contrast-Enhanced Breast CT vs DBT and Mammography, British Journal of Radiology
Multi-Marker Quantitative Radiomics for Mass Characterization, Medical Physics
Breast CT: Screening Technique of the Future, Current Breast Cancer Reports
Simulated Lesion, Human Observer Performance Comparison, Physics in Medicine & Biology
Differentiation of DCIS, European Journal of Radiology
Dedicated Breast CT: Initial Clinical Experience, Radiology
Radiation Dose in Breast CT, Medical Physics
Computed Tomography for Imaging the Breast, Springer Science
Dedicated Breast CT: Radiation Dose and Image Quality Evaluation, Medical Physics
Breast CT Clinical Images
Same Breast Images on Different Modalities
Breast CT 3D Reconstruction & Image Slices
Breast CT Clinical Images
Disclaimer: IzoView & Breast CT Technology
Izotropic Corporation holds the exclusive global licensing rights to breast CT technology from the Regents of the University of California. This technology was originally developed at the University of California, Davis, under the Breast Tomography Project led by Company Director Dr. John Boone and his clinical collaborators. Four successive breast CT research devices were developed and evaluated at UC Davis. The clinical data and images referenced by the Company were generated using these research prototypes. IzoView, the commercial breast CT system developed by Izotropic Corporation, is a distinct and separate device designed for commercial use and was not used to generate this data or these images.
Accordingly, any clinical performance data or images referenced by the Company should not be interpreted as evidence of IzoView’s abilities, safety or effectiveness. IzoView remains an investigational device and has not been evaluated in clinical trials or studies to support claims of diagnostic performance. No assurances are made that results achieved with earlier breast CT systems will be replicated with IzoView. The Company makes no claims or guarantees regarding the diagnostic capabilities, clinical benefits, or regulatory approval of IzoView at this time.
IzoView has not been approved or cleared by any regulatory authority and is not yet available for commercial sale. Any statements regarding potential clinical utility are for informational purposes only.